Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice
- PMID: 14638514
- PMCID: PMC296198
- DOI: 10.1128/AAC.47.12.3976-3978.2003
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice
Abstract
We have evaluated the efficacy of voriconazole (VRC) in a murine model of systemic infection by Scedosporium apiospermum. The survival of mice treated with VRC at 5, 20, or 40 mg/kg/day was greater than that of the control group (P< or =0.0009). VRC reduced the tissue burden in the spleen and brain (P<0.001 in both organs) in comparison with that of the control group.
Figures
References
-
- Berenguer, J., J. Diaz-Mediavilla, D. Urra, and P. Muñoz. 1989. Central nervous system infection caused by Pseudallescheria boydii. Rev. Infect. Dis. 11:890-896. - PubMed
-
- Cano, J., J. Guarro, E. Mayayo, and J. Fernández-Ballart. 1992. Experimental infection with Scedosporium inflatum. J. Med. Vet. Mycol. 30:413-420. - PubMed
-
- Espinel-Ingroff, A., K. Boyle, and D. J. Sheehan. 2001. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia 150:101-115. - PubMed
-
- Fuhr, U. 1998. Drug interactions with grapefruit juice: extent, probable mechanism and clinical relevance. Drug Safety 18:251-272. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
